C3.ai, Inc. (AI) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

Founded in 2009 by Thomas Siebel, C3.ai's core purpose has always been to deliver AI solutions to enterprises. Its value ...

Investing.com -- Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) stock surged 12% after the U.S. Food and Drug Administration (FDA) approved EMPAVELI® (pegcetacoplan) as the first treatment for C3 ...

The FDA approved pegcetacoplan (EMPAVELI; Apellis Pharmaceuticals) as the first treatment for patients aged 12 and older with the rare, severe kidney diseases C3 glomerulopathy (C3G) and primary ...

The XIAO Smart IR Mate is a compact circular-shaped IR remote hub/blaster built around the XIAO ESP32-C3 and designed for IoT ...

The Soundside Music Festival, scheduled to take place in September with headliners like the Killers, Hozier, and Vampire Weekend, has been canceled.

Inside the Wild Freeride Summer Camp Hosted by This MTB Legend originally appeared on BikeMag.

Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of C3.ai's market ...

AI stock fell on Thursday after software maker C3.ai said its chief executive, Thomas Siebel, will step down for health ...

The free summer concert series at the Museum of Early Trades & Crafts will continue with a performance by the C3 Soul Revue, ...

The stocks bucked a mostly optimistic broader market, with the tech-heavy Nasdaq and the S&P 500 both up by 0.18 percent and ...

C3.ai announced today that CEO Tom Siebel would be stepping down and that the company was in the process of looking for its ...